Mpm Bioventures 2018, L.P.
CIK 0001729505
10% Owner
Filings
4
Latest Jan 14, 2026
Issuers covered
3
Showing
4 of 4
Page 1
Track record
3 of 9 open-market trades scored (33% price coverage) - 6 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 67% | +12.7% | +26.4% | +28.6% | -17.0% |
| 90 days | 3 | 67% | +25.0% | +46.5% | +48.8% | -20.3% |
| 180 days | 2 | 100% | +59.9% | +59.9% | +60.5% | +59.2% |
| 365 days | 2 | 100% | +47.0% | +47.0% | +48.4% | +45.7% |
Issuers
Companies where Mpm Bioventures 2018, L.P. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ITOS | Iteos Therapeutics, Inc. | 2 | May 15, 2025 |
| AKTS | Aktis Oncology, Inc. | 1 | Jan 14, 2026 |
| TRDA | Entrada Therapeutics, Inc. | 1 | Dec 12, 2024 |
All filings
4 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|